RYBOX Mutual Fund
RYBOX Mutual Fund
RYBOX Mutual Fund
Rydex Biotechnology Fund Class A
RYBOX Mutual Fund Overview
RYBOX Mutual Fund (Rydex Biotechnology Fund Class A) is managed by Rydex Funds with $16.1M in net assets. RYBOX expense ratio is 1.64%, holding 75 positions across sectors including Health Care. Inception date: 2004-09-01.
RYBOX performance shows a YTD return of 18.77%. The 1-year return is 79.03% and the 5-year return is 11.38%. RYBOX dividend yield stands at 12.78%, paid annually.
RYBOX top holdings include Abbvie Inc Health Care (7.4%), Amgen Inc. Com (5.2%), Gilead Sciences Inc (5.0%), Vertex Pharmaceuticals Inc (4.0%), Regeneron Pharmaceuticals, Inc. (3.6%). Go to all RYBOX holdings, RYBOX sectors, or RYBOX dividends.
RYBOX can be compared against other funds. Use RYBOX overlap to find shared positions, or RYBOX vs another fund for a side-by-side view. RYBOX alternatives are available via the screener, along with tax-loss harvesting opportunities.